West Pharmaceutical Services (WST) Prepaid Assets (2009 - 2026)

West Pharmaceutical Services (WST) has reported Prepaid Assets for 18 consecutive years, with $212.3 million the latest figure, recorded in Q2 2026.

• Quarterly Prepaid Assets rose 26.6% year-over-year to $212.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $212.3 million (up 26.6% YoY) and the FY2025 annual result came in at $168.6 million, up 35.97% from the prior year.
• Prepaid Assets climbed to $212.3 million in Q2 2026 per WST's latest filing, from $167.2 million in the prior quarter.
• Over the last five years, Prepaid Assets for WST reached as high as $212.3 million in Q2 2026 and fell as low as $90.5 million in Q1 2023.
• A 5-year average of $131.9 million and a median of $127.9 million in 2024 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2022 — Prepaid Assets jumped 59.64% — and 2023, when it fell 16.43%.
• Year by year, Prepaid Assets stood at $103.0 million in 2022, then soared by 31.84% to $135.8 million in 2023, then fell by 8.69% to $124.0 million in 2024, then jumped by 35.97% to $168.6 million in 2025, then grew by 25.92% to $212.3 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $212.3 million, $167.2 million, and $168.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.